Technology

  Market Analysis: The  global Pulmonary Drug Delivery Systems market  was valued at approximately US$ 3,305 million in 2024 and is projected to reach around US$ 4,391 million by 2031, reflecting a CAGR of 4.2% during the forecast period from 2025 to 2031. The global pulmonary drug delivery systems market is witnessing consistent growth due to the increasing prevalence of respiratory diseases such as asthma, COPD, and cystic fibrosis. Pulmonary drug delivery provides a non-invasive, targeted, and rapid mode of drug administration, which has made it a preferred route for both local and systemic therapies. The integration of advanced inhalation technologies and smart inhalers further strengthens market demand, particularly in developed regions with strong healthcare infrastructure. Get Free Sample Report:  https://www.qyresearch.in/request-sample/medical-devices-consumables-global-pulmonary-drug-delivery-systems-market-insights-industry-share-sales-projections-and-dema...